Citrus flavonoid glycoside

Plain-language summaryIntrigue 45 / 100

Hesperidin is a citrus flavonoid glycoside abundant in orange peel. It has antioxidant and vascular-protective effects. The glucosylated form (G-hesperidin) is much better absorbed than native hesperidin. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Our opinion on this compoundEstablished workhorse

32/100

Mature citrus flavonoid with real venous-indication data but negligible frontier research value

Look, hesperidin is a real compound with real clinical use. The MPFF formulation (Daflon) has legitimate phase 3 data for chronic venous insufficiency and hemorrhoids, and thats more than most supplements can claim. We dont want to dismiss that. But the question the rubric is asking is whether a bench scientist should be prioritizing this in 2025, and the honest answer is almost certainly no.

The mechanism story is what kills it. Hesperidin operates through the standard polyphenol toolkit: NF-kB pathway modulation, antioxidant activity, some inhibition of prostaglandin and leukotriene synthesis, mild influence on venous smooth muscle tone. These are not bad mechanisms. They’re just not interesting mechanisms. Every citrus flavonoid researcher has been staring at this same biology since the 1990s. Theres no novel target, no dual-action angle, nothing that makes you sit up.

The clinical attribution problem is real and underappreciated. Most of the solid human data comes from MPFF, which is a 90:10 diosmin-to-hesperidin combination. Isolating hesperidin’s contribution is methodologically messy, and the literature for hesperidin monotherapy in humans is considerably thinner. You get some small-N trials on blood pressure, some cognitive signal in older adults from a 2015 Nutrients paper, modest metabolic effects. The replication is inconsistent. We’d call this a 50 on evidence for the MPFF-supported indications, but that credit is partly borrowed.

Whats interesting, if anything, is the gut conversion angle. Hesperetin (the aglycone) is the bioavailable form, and the gut microbiome conversion rate varies dramatically between individuals. There’s genuine mechanistic work to do on why some people absorb essentially none of this and others convert efficiently. That question connects to broader microbiome-flavonoid interaction research. But that’s a story about gut biology using hesperidin as a probe, not a story about hesperidin as a therapeutic target.

Sourcing is trivial. Purity is generally fine from standard vendors. Stack interactions are minimal. None of this makes it exciting research; it makes it a compound that sits in a lot of backgrounds without causing trouble. For investigators building a library, its a low-priority inclusion. If your research program specifically concerns venous biology, flavonoid pharmacokinetics, or microbiome-mediated polyphenol conversion, it earns a spot. Otherwise, theres a long list of compounds ahead of it.

Novelty: 20
Mechanism promise: 22
In-category differentiation: 30
Evidence quality: 50
Translational signal: 45
Research bench value: 30

Rationale Hesperidin scores low on novelty and mechanism because it’s a decades-old polyphenol with well-understood, unremarkable flavonoid pharmacology; the MPFF/Daflon clinical record lifts evidence and translational scores somewhat, but the combination-product attribution problem limits how much credit hesperidin alone can claim, and the raw weighted score lands comfortably below any applicable cap.

Citrus flavonoid glycoside

A flavanone glycoside from citrus peel with vascular and anti-inflammatory effects; the principal active in Daflon.

Abstract

Hesperidin (CAS 520-26-3; molecular formula C28H34O15; molecular weight 610.57) is a flavanone glycoside present in high concentrations in citrus peel and pith. The aglycone form (hesperetin) is the bioavailable active. The compound has documented vascular effects (improved venous tone, reduced capillary fragility) and is used clinically as part of micronized purified flavonoid fraction (MPFF, Daflon) for chronic venous insufficiency and hemorrhoids. The compound is sold as a dietary supplement. Doses are typically 500 mg to 1 gram per day.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, sourcing and quality verification, and a curated reference list. Embedded inline below; download for offline reading.

KDC-MN-188Open in new tab →

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Tag: Citrus flavonoid glycoside

Hesperidin

Abstract

Read the full monograph